PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 10, 2002Circulation2,204 citations

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

View Full Paper
BABirgit AßmusVSVolker SchächingerCTClaudius Teupe

Key Points

  • This research aims to assess the safety and efficacy of autologous progenitor cell transplantation in treating ischemic heart disease post-myocardial infarction.
  • 20 patients with reperfused acute myocardial infarction were randomly allocated to receive either bone marrow-derived (n=9) or blood-derived progenitor cells (n=11).
  • Intracoronary infusion was performed 4.3±1.5 days after myocardial infarction.
  • Outcomes were measured using echocardiography and F-18-fluorodeoxyglucose-positron emission tomography at 4 months.
  • Significant increase in left ventricular ejection fraction from 51.6±9.6% to 60.1±8.6% (P=0.003).
  • End-systolic left ventricular volumes significantly reduced from 56.1±20 mL to 42.2±15.1 mL (P=0.01).
  • Myocardial viability in the infarct zone increased significantly (P<0.01) with no adverse effects reported.

Abstract

BACKGROUND: Experimental studies suggest that transplantation of blood-derived or bone marrow-derived progenitor cells beneficially affects postinfarction remodeling. The safety and feasibility of autologous progenitor cell transplantation in patients with ischemic heart disease is unknown. METHODS AND RESULTS: We randomly allocated 20 patients with reperfused acute myocardial infarction (AMI) to receive intracoronary infusion of either bone marrow-derived (n=9) or circulating blood-derived progenitor cells (n=11) into the infarct artery 4.3+/-1.5 days after AMI. Transplantation of progenitor cells was associated with a significant increase in global left ventricular ejection fraction from 51.6+/-9.6% to 60.1+/-8.6% (P=0.003), improved regional wall motion in the infarct zone (-1.5+/-0.2 to -0.5+/-0.7 SD/chord; P<0.001), and profoundly reduced end-systolic left ventricular volumes (56.1+/-20 mL to 42.2+/-15.1 mL; P=0.01) at 4-month follow-up. In contrast, in a nonrandomized matched reference group, left ventricular ejection fraction only slightly increased from 51+/-10% to 53.5+/-7.9%, and end-systolic volumes remained unchanged. Echocardiography revealed a profound enhancement of regional contractile function (wall motion score index 1.4+/-0.2 at baseline versus 1.19+/-0.2 at follow-up; P<0.001). At 4 months, coronary blood flow reserve was significantly (P<0.001) increased in the infarct artery. Quantitative F-18-fluorodeoxyglucose-positron emission tomography analysis revealed a significant (P<0.01) increase in myocardial viability in the infarct zone. There were no differences for any measured parameter between blood-derived or bone marrow-derived progenitor cells. No signs of an inflammatory response or malignant arrhythmias were observed. CONCLUSIONS: In patients with AMI, intracoronary infusion of autologous progenitor cells appears to be feasible and safe and may beneficially affect postinfarction remodeling processes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Aßmus et al. (2002) studied this question.

synapsesocial.com/papers/6a03bfd2d2c35e4200e96ac1https://doi.org/10.1161/01.cir.0000043246.74879.cd
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects1985 · 1,515 citations
  2. 2Mobilized bone marrow cells repair the infarcted heart, improving function and survival2001 · 2,092 citations
  3. 3Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction1992 · 5,971 citations
  4. 4Quantitative relationship between global left ventricular thallium uptake and blood flow: effects of propranolol, ouabain, dipyridamole, and coronary artery occlusion.1986 · 50 citations
  5. 5Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease2000 · 2,593 citations